Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights

Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...

Daiichi Sankyo’s COVID-19 shot to get regulatory approval

Japan’s first domestically produced vaccine for the virus that causes COVID-19 has been cleared for regulatory approval.
China Daily Global Edition

Japan to extend COVID-19 emergency measures in half of prefectures under restrictions

TOKYO - The Japanese government on Thursday is set to announce that the current COVID-19 quasi-emergency measures in place ...

Doctors Say Hantavirus Is 'More Forgiving' Than COVID-19—Here's What That Means Exactly

With the recent contractions of hantavirus on a cruise ship, many are wondering how hantavirus differs from COVID-19.
Hosted on MSN

Italy and France probe suspected third-generation hantavirus cases

New suspected cases: Italy and France are testing individuals possibly infected by secondary contacts from the MV Hondius ...